6640
P. A. E6ans, T. Manangan / Tetrahedron Letters 42 (2001) 6637–6640
8. Evans, P. A.; Manangan, T.; Rheingold, A. L. J. Am.
59.52 (o), 56.29 (o), 46.97 (o), 32.01 (e), 26.75 (o), 25.78
(e), 19.17 (e); HRMS (CI, M+) calcd for C39H40N2O6Si
660.2656, found 660.2662.
Chem. Soc. 2000, 122, 11009.
9. For the preparation of 3-N-benzoyluracil and thymine,
see: Cruickshank, K. A.; Jiricny, J.; Reese, C. B. Tetra-
hedron Lett. 1984, 25, 681.
10. For a recent review on the Mitsunobu reaction, see:
Hughes, D. L. Org. React. 1992, 42, 335. For a related
example using maleimide, see: Walker, M. A. J. Org.
Chem. 1995, 60, 5352.
11. Yuasa, Y.; Kano, S.; Shibuya, S. Heterocycles 1991, 32,
2311.
12. Evans, P. A.; Roseman, J. D.; Garber, L. T. Synth.
Commun. 1996, 26, 4685.
15. For a recent reviews on this reagent, see: (a) Chat-
gilialoglu, C. Acc. Chem. Res. 1992, 25, 188; (b) Chat-
gilialoglu, C.; Ferreri, C.; Gimisis, T. In The Chemistry of
Organic Silicon Compounds; Rappoport, S.; Apeloig, Y.,
Eds.; Wiley: London, 1998; Vol. 2, Chapter 25, p. 1539.
16. For related examples of the intramolecular addition of
aryl and alkyl radicals to uracil derivatives, see: (a)
Yoshimura, Y.; Otter, B. A.; Ueda, T.; Matsuda, A.
Chem. Pharm. Bull. 1992, 40, 1761; (b) Zhang, W.; Pugh,
G. Tetrahedron Lett. 1999, 40, 7591 and pertinent refer-
ences cited therein.
17. For a related example of a stereoselective free radical
cyclization where a similar nonbonding interaction is
invoked to rationalize the trans-diastereoselectivity, see:
(a) Hart, D. J.; Kanai, K. J. Am. Chem. Soc. 1983, 105,
1255; (b) Beckwith, A. L. J.; Joseph, S. P.; Mayadunne,
R. T. A. J. Org. Chem. 1993, 58, 4198.
18. For recent reviews on alkyl and acyl radicals in synthesis,
see: (a) Curran, D. P. In Comprehensive Organic Synthe-
sis; Trost, B. M.; Fleming, I., Eds.; Pergamon: Oxford,
1992; Vol. 4; (b) Chatgilialoglu, C.; Crich, D.; Komatsu,
M.; Ryu, I. Chem. Rev. 1999, 99, 1991 and pertinent
references cited therein.
19. McCauley, J. A.; Nagasawa, K.; Lander, P. A.; Mischke,
S. G.; Semones, M. A.; Kishi, Y. J. Am. Chem. Soc. 1998,
120, 7647.
13. Batty, D.; Crich, D. Synthesis 1990, 273.
1
14. All new compounds exhibited spectroscopic (IR, H and
13C NMR) and analytical (HRMS) data in accord with
the assigned structure. Representative data given for
compound 14: [h]1D9 +1.52 (c=1.1, CHCl3); IR (CDCl3)
3018 (m), 2957 (m), 2930 (m), 2858 (m), 1752 (s), 1706 (s),
1
1662 (s) cm−1; H NMR (400 MHz, CDCl3) l 7.99–7.20
(m, 4H), 7.59–7.51 (m, 6H), 7.41–7.29 (m, 8H), 7.24–7.20
(m, 2H), 4.82 (dd, J=3.5, 11.8, 1H), 4.77 (dd, J=4.2,
11.8, 1H), 4.30 (dd, J=3.6, 10.4, 1H), 4.19–4.07 (m, 2H),
3.57 (dd, J=1.6, 10.4 Hz, 1H), 2.94 (dt, J=3.8, 12.2 Hz,
1H), 2.58–2.51 (m, 1H), 2.25–2.13 (m, 2H), 1.84–1.73 (m,
1H), 0.97 (s, 9H); 13C NMR (100 MHz, CDCl3) l 169.45
(e), 168.28 (e), 166.10 (e), 148.85 (e), 135.52 (o), 135.44
(o), 134.55 (o), 133.38 (e), 132.86 (e), 132.64 (e), 132.51
(e), 130.19 (o), 129.84 (o), 129.71 (o), 129.30 (e), 129.01
(o), 128.50 (o), 127.78 (o), 127.74 (o), 62.95 (e), 59.94 (e),